But with speed comes risk
One possible reason is that the dose of semaglutide is higher for weight loss, and higher doses may be more likely to cause side effects than lower doses
Of particular interest to researchers is Retatrutides triple agonist mechanism, which published Phase 2 data suggests produces distinct and potentially additive metabolic effects compared to both selective GLP-1 agonists and dual GIP/GLP-1 agonists
New Research Highlights an Unusual Side Effect of GLP-1 Weight Loss Medications Medications such as Ozempic, Wegovy and Mounjaro have changed the landscape of weight loss treatment in Australia and globally
Moreover, CKD is associated with development of CVD including arterial stiffness, hypertension and cardiac dysfunction [122]
Drinking enough fluids, staying active and eating fibre-containing foods may help